FEATURED
1 min.Read

JN White Introduces the SnaggleClaw™

J.N. White Associates, Inc. (announced today that it is launching the SnaggleClaw™: a new multipurpose, touchless tool that limits exposure to pathogens.

The JN White ®  SnaggleClaw™is to be used in situations where an individual risks exposure to COVID-19.

This tool provides a safer alternative to touching in everyday activities, such as operating touchscreens, keypads and door handles. In addition, the tool contains an antimicrobial coating that offers an additional layer of defense against pathogens.

JN White® is an ISO 9001:2015 and ITAR-certified custom manufacturer specializing in the design and production of membrane switches, graphic overlays and custom labels. The company works with a wide range of global companies in many industries including military/DoD, medical devices and appliances. In response to the coronavirus pandemic, JN White® moved into the development and production of Personal Protective Equipment (PPE).

When asked why the firm continues to expand into new PPE products, JN White® President, Jason Aymerich, explains, “JN White® continues to innovate where the market has a need.  Providing solutions in the PPE space furthers the firm’s commitment to helping our country stay strong.”

SplatterGuard and SnaggleClaw are trademarks of J.N. White Associates, Inc. JN White and Precision Answers are registered trademarks of J.N. White Associates, Inc. 

Hot this week

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

0
Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

0
EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

0
The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

0
Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

0
Haemonetics notes the VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.

About us

Medical Device News Magazine

Welcome to Medical Device News Magazine, a digital publication providing up to the minute medical device and biotechnology news.

Need to know more?

Contact us

Navigation

Florida, New York, No. Carolina
United States
Phone Number: 1.561.316.3330